Department of Medical BioSciences, Research Institute for Medical Innovation, Radboud university medical center, PO Box 9101, Nijmegen, 6500 HB, The Netherlands.
MedSkin Solutions Dr. Suwelack AG, 48727, Billerbeck, Germany.
Adv Healthc Mater. 2024 Oct;13(27):e2400484. doi: 10.1002/adhm.202400484. Epub 2024 Jul 11.
Elastin, a fibrous extracellular matrix (ECM) protein, is the main component of elastic fibers that are involved in tissues' elasticity and resilience, enabling them to undergo reversible extensibility and to endure repetitive mechanical stress. After wounding, it is challenging to regenerate elastic fibers and biomaterials developed thus far have struggled to induce its biosynthesis. This review provides a comprehensive summary of elastic fibers synthesis at the cellular level and its implications for biomaterial formulation, with a particular focus on dermal substitutes. The review delves into the intricate process of elastogenesis by cells and investigates potential triggers for elastogenesis encompassing elastin-related compounds, ECM components, and other molecules for their potential role in inducing elastin formation. Understanding of the elastogenic processes is essential for developing biomaterials that trigger not only the synthesis of the elastin protein, but also the formation of a functional and branched elastic fiber network.
弹性蛋白是一种纤维细胞外基质(ECM)蛋白,是弹性纤维的主要成分,参与组织的弹性和回弹性,使它们能够进行可逆的伸展,并耐受反复的机械应力。在受伤后,再生弹性纤维具有挑战性,并且迄今为止开发的生物材料在诱导其生物合成方面遇到了困难。本综述全面总结了细胞水平上弹性纤维的合成及其对生物材料配方的意义,特别关注皮肤替代品。该综述深入探讨了细胞弹性蛋白生成的复杂过程,并研究了弹性蛋白生成的潜在触发因素,包括弹性蛋白相关化合物、细胞外基质成分和其他分子,以探索它们在诱导弹性蛋白形成中的潜在作用。了解弹性蛋白生成过程对于开发生物材料至关重要,这些生物材料不仅可以触发弹性蛋白的合成,还可以形成功能性和分支的弹性纤维网络。